Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Are genetic approaches still needed to cure sickle cell disease?
Robert A. Brodsky, Michael R. DeBaun
Robert A. Brodsky, Michael R. DeBaun
Published November 18, 2019
Citation Information: J Clin Invest. 2020;130(1):7-9. https://doi.org/10.1172/JCI133856.
View: Text | PDF
Viewpoint Article has an altmetric score of 4

Are genetic approaches still needed to cure sickle cell disease?

  • Text
  • PDF
Abstract

Authors

Robert A. Brodsky, Michael R. DeBaun

×

Total citations by year

Year: 2025 2021 2020 Total
Citations: 1 4 2 7
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (7)

Title and authors Publication Year
Preclinical efficacy of a modified gamma-globin lentivirus gene therapy in Berkeley sickle cell anemia mice and human xenograft models
Shrestha A, Pillis DM, Felker S, Chi M, Wagner K, Gbotosho OT, Sieling J, Shadid M, Malik P
Molecular Therapy. Methods & Clinical Development 2025
Genetic Therapies for the First Molecular Disease
Phillip Doerfler, Akshay Sharma, Jerlym Porter, Yan Zheng, Mitchell Weiss
Journal of Clinical Investigation 2021
Complement in Sickle Cell Disease: Are We Ready for Prime Time?
C Varelas, A Tampaki, I Sakellari, Α Anagnostopoulos, E Gavriilaki, E Vlachaki
Journal of blood medicine 2021
Research in Sickle Cell Disease: From Bedside to Bench to Bedside
GS Cisneros, SL Thein
2021
Leukemia after gene therapy for sickle cell disease: insertional mutagenesis, busulfan, both, or neither
RJ Jones, MR DeBaun
Blood 2021
SARS-CoV-2 antibody characterization in emergency department, hospitalized and convalescent patients by two semi-quantitative immunoassays
HS Yang, SE Racine-Brzostek, WT Lee, D Hunt, J Yee, Z Chen, J Kubiak, M Cantu, L Hatem, E Zhong, D D'Ambrosio, A Chadburn, L Westblade, M Glesby, M Loda, MM Cushing, Z Zhao
Clinica chimica acta; international journal of clinical chemistry 2020
The Meaning of Informed Consent: Genome Editing Clinical Trials for Sickle Cell Disease
S Desine, BM Hollister, KE Abdallah, A Persaud, SC Hull, VL Bonham
AJOB Empirical Bioethics 2020

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Posted by 5 X users
On 2 Facebook pages
27 readers on Mendeley
See more details